| Valuation method | Value, € | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | n/a | n/a |
| Intrinsic value (DCF) | n/a | |
| Graham-Dodd Method | n/a | |
| Graham Formula | n/a |
Carvolix is a medical technologies company in the commercial and clinical stage, which engages in the provision of structural heart disease and brain stroke treatment. It develops AI- and imaging-driven mini-robots that make complex procedures and biomimetic heart valves. The company was founded on January 30, 2026 and is headquartered in Aix-en-Provence, France.